Catalent Brass Face Investor Suit Over COVID Vaccine Woes

By Sydney Price · August 15, 2023, 1:44 PM EDT

The top brass of pharmaceutical company Catalent Inc. face a shareholder derivative suit in Delaware federal court over claims they lied to investors about the health of the company's finances and...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Husty v. Catalent, Inc. et al

Case Number

1:23-cv-00891

Court

Delaware

Nature of Suit

Stockholders Suits

Date Filed

August 11, 2023